Lenvatinib Plus VIC-1911 in Lenvatinib-unresponsive or Lenvatinib-resistant HCC

Clinical trial NCT05718882 · TERMINATED

Trial details

NCT number: NCT05718882
Sponsor: RenJi Hospital
Status: TERMINATED
Phase: Not Applicable
Study type: INTERVENTIONAL

Liver Cancer Hepatocellular Carcinoma Resistant Cancer

Start date: 2023-08-30
Primary completion: 2024-04-02
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.